Estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER2) are important and well-established prognostic and predictive biomarkers for breast cancers and routinely tested on patient’s tumor samples by immunohistochemical (IHC) study. Here, ERBB2 is linked to neoplasm.